Jump to content
IGNORED

Covid-19: Razvoj vakcine, imunitet i primena medikamenata


beyoncé

Recommended Posts

https://www.google.com/amp/s/amp.smh.com.au/politics/federal/australian-covid-vaccine-terminated-due-to-hiv-false-positives-20201210-p56mju.html

Sad ce Ozi vlada da naruci dodatne kolicine od nekog iz trija Moderna-JNJ-Fajzer

Link to comment
4 hours ago, April said:

 

Meni zvuči realno - osam hiljada zaraženih dnevno poslednjih mesec dana puta deset je blizu dva ipo miliona. Dakle, ovim tempom u januaru prebacujemo 4 milke i ćao korona.

 

pa to. reko liktm

Link to comment
6 hours ago, Jumanji said:

Britanci objavili ko ne sme da koristi Pfizer/BioNTech vakcinu

 

 

 

Guglao, kaze Gugl 0.05-2% u SAD i oko 3% u Evropi ucestalost anafilaksije.

Edited by Budja
Link to comment

Ako se br. obolelih mnozi sa 10 onda je CG na 400.000 što bi uz policijski čas moralo da da ozbiljne rezultate, a tamo nema nekog pada brojeva. 

Ne znam, čas mislim ma ovo prolazi, čas mislim ovako će da roka do jula

Edited by yabadaba
Link to comment

x10 obicna glupost.

Moja CG savrsen primjer do sada. 40k samo 6.6% sa svim asimtomaticnim max 15%.

Ovi asimtomaticni nijesu razvili neki jak imunitet jer su uglavnom bili slabo izlozeni virusu i kao i ostali ce u velikom procentu primiti vakcinu.

 

jos jednom, Astrino istrazivanje na 23k je pokazalo da je manje od x2 ukljucujuci i one sa blagim ne-standardnim simptomima.

  • +1 1
Link to comment
4 hours ago, vememah said:

Ne mož' ruska da ne bude najefikasnija pa to ti je.

 

https://tass.com/society/1233489

:rolf:

Stvarno smijurija. Izabrali su kontrlonu grupu 3x manju od vakcinske pa podesavaju podatke da budu na prvom mjestu.

Stvarno steta, jer moguce da je odlican proizvod ali zbog naredjenja iz Kremlja moraju da steluju cifre o efikasnosti.

JNJ i Novavax ce za mjesec dana iskociti sa svojim procjenama pa cemo vidjet jel Oksofordska prihvatljiva ili nije

Link to comment

Ameri odobrili Fajzerovu vakcinu, plan je da, ako za koji dan odobre i Moderninu, za nešto više od dva i po meseca vakcinišu 100 miliona ljudi: 20 miliona do kraja decembra, još 30 miliona do kraja januara i još 50 miliona do kraja februara. To je dakle nešto manje od trećine stanovništva pošto SAD trenutno ima oko 330 miliona.

 

Quote

 

DECEMBER 12, 2020, 4:05 AM, UPDATED 8 HOURS AGO

Explainer: U.S. has authorized the first COVID-19 vaccine - when will I get it?

By Rebecca Spalding

4 MIN READ

(Reuters) - The U.S. Food and Drug Administration authorized the first COVID-19 vaccine developed by Pfizer Inc and BioNTech SE , making it available for emergency use to patients aged 16 and older.

In clinical trials, the vaccine was 95% effective at preventing illness and showed no short-term safety issues.

The following is an outline of vaccine distribution plans.

WHAT HAPPENS NEXT?

The federal government plans to release the nation’s first 2.9 million doses within days of the authorization to 64 states, U.S. territories and major cities, as well as five federal agencies. Although the federal government is coordinating distribution efforts, states have the final decision over who gets the first shots. The federal government is sending the first shipments to more than 600 locations.

WHO IS FIRST IN LINE FOR A SHOT?

States are prioritizing healthcare workers and elderly long-term care residents for the first vaccinations. There are about 21 million healthcare workers in the United States and 3 million nursing home residents. Most states anticipate they will be able to vaccinate only between 13% and 18% of their healthcare workers with the first distribution, a Reuters analysis found. The federal government has said it will continue to send out millions of doses each week but has not released exact figures.

WHO IS NEXT IN LINE?

States have broad discretion over who will get the vaccine next. So far, a panel advising the Centers for Disease Control and Prevention (CDC) has only issued the guidance that healthcare workers and nursing home residents should be first.

The CDC has laid out a possible framework of three distribution phases, suggesting essential workers and people aged 65 and older as the next priority.

Some states have indicated they plan to give essential workers priority after healthcare workers and nursing home residents receive the vaccine.

At least 20 large industries are lobbying states to get their workers classified as essential, a Reuters analysis found, including Uber Technologies Inc, DoorDash Inc, and others.

WILL THERE BE ENOUGH VACCINES TO GO AROUND?

Pfizer has said it would make 50 million doses this year - enough to inoculate 25 million people - about half of which would go to the United States. Pfizer has an agreement with the U.S. government to supply a total of 100 million doses, enough for 50 million people to be vaccinated. The United States has an option to buy an additional 500 million doses.

An panel of expert advisers to the FDA will review a second COVID-19 vaccine from Moderna Inc next week. If that vaccine is authorized, federal officials have said they will be able to vaccinate 20 million Americans in December, 30 million in January, and 50 million in February.

Johnson & Johnson and AstraZeneca Plc also have vaccines in late-stage trials. If those vaccines receive authorization early next year, officials said there would be enough doses to vaccinate about 75 million Americans a month by about March or April.

Officials said by the middle of next year, the United States will have distributed enough vaccines for most Americans who want the vaccine to be inoculated.

WHAT HAPPENS ONCE I GET THE VACCINE?

The vaccine is given in two shots, three weeks apart. Pfizer has said side effects in trial volunteers were mostly mild to moderate, and cleared up quickly. The most severe side effects occurred after the second dose, including flu-like symptoms, fatigue and headache.

Although the vaccine was shown to be highly effective at preventing illness, there is no data yet that suggests it also prevents infection or the ability to spread the virus to others. Mask-wearing and social distancing will likely remain in place until more people are vaccinated or proof emerges that the vaccine also prevents virus transmission.

 

https://www.reuters.com/article/health-coronavirus-vaccine-distribution/explainer-u-s-has-authorized-the-first-covid-19-vaccine-when-will-i-get-it-idUKL1N2IQ25X

Edited by vememah
Link to comment

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...